William Blair Thinking
Enhancing Results With a Buy-Side Debt Advisor
Buy-side financing has become increasingly complex, with direct lending dominating middle-market leveraged buyouts and acquisitions. New lenders and strategies have emerged, while investment committees have become fickle and are frequently deterred by complex credit stories.
Watch the videoFlirting With and Dating Recessions
Timing an economic recession is never easy, as proved this past year. In this report, we take a snapshot of where the main indicators are today, and what some of the more forward-looking data suggest.
Read moreEmerging Markets Debt: 3 Ways We Are Differentiated
As fundamental emerging markets debt investors, we believe our distinct approach, our dynamic mindset, and our diverse team helps to enable us to deliver better potential outcomes for our portfolios and clients.
Watch the videoOur Mission, Vision, and Values
At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.
Learn more about our mission, vision, and values
Community Engagement at William Blair
"Our job is to bridge the gap between those students who live in underserved communities and the financial industry. What William Blair has done has fully bought into our model of getting to know these young people, understanding their background, and understanding what we are trying to achieve. If not for William Blair, we would not be where we are today.”
Bevon Joseph, Co-Founder of Greenwood Project
Our Latest News
Former U.S. Army Captain Demonstrated ‘Leading with Resilience Through Difficult Times’
Former U.S. Army Captain Wes Becton shared his thoughts on resiliency learned during his military career and what it means during hard times at William Blair’s annual Veterans Day celebration.
Read moreCabaletta Bio, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Cabaletta Bio, Inc. (CABA $13.69), a clinical-stage company focused on the development and commercialization of first-in-class immune cell therapies for the treatment of severe autoimmune disorders.
Read moreHqO Raises Series D Funding Led by Koch Real Estate Investments
William Blair acted as financial advisor to HqO, Inc., in connection with its over $50 million Series D funding round, led by Koch Real Estate Investments, a subsidiary of Koch Industries, along with participation from existing investors, including Accomplice, Insight Partners, and Related.
Read moreJoin Our Team
Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.
Search for jobs and apply
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights